| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
16.65(B) |
| Last
Volume: |
2,015,098 |
Avg
Vol: |
1,968,864 |
| 52
Week Range: |
$52.73 - $83.72 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 8.8 |
| Insider 6 Months : 8.8 |
| Insider 3/6 Months : 18 |
|
| Guru Rank Number : 411 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
5,445 |
5,445 |
5,445 |
5,445 |
| Total Buy Value |
$300,760 |
$300,760 |
$300,760 |
$300,760 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
139,854 |
262,967 |
| Total Sell Value |
$0 |
$0 |
$11,209,021 |
$20,111,490 |
| Total People Sold |
0 |
0 |
6 |
9 |
| Total Sell Transactions |
0 |
0 |
7 |
15 |
| End Date |
2025-03-27 |
2024-12-24 |
2024-06-25 |
2023-06-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schnittker Brandon |
Div. President, GYN Surgical |
• • – |
2025-05-30 |
4 |
D |
$62.17 |
$4,290 |
D/D |
(69) |
6,094 |
|
- |
|
| Madaus Martin D |
Director |
• • – |
2025-05-07 |
4 |
B |
$55.24 |
$300,760 |
I/I |
5,445 |
5,445 |
2.1 |
17% |
|
| Liddy Anne M. |
General CounselOfficer |
• – – |
2025-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,426 |
|
13% |
|
| Mcmillan Wayde D. |
Director |
• • – |
2025-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,742 |
1,742 |
|
- |
|
| Madaus Martin D |
Director |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,864 |
2,206 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,864 |
3,436 |
|
- |
|
| Wendell Amy Mcbride |
Director |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,864 |
22,594 |
|
- |
|
| Mohtashami Nanaz |
Director |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,864 |
4,181 |
|
- |
|
| Stamoulis Christiana |
Director |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,864 |
47,336 |
|
- |
|
| Hantson Ludwig |
Director |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,864 |
12,956 |
|
- |
|
| Stewart Stacey D. |
Director |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,864 |
5,168 |
|
- |
|
| Horvath Mark W. |
Div. Pres., Breast & Skeletal |
• • – |
2025-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
958 |
7,057 |
|
- |
|
| Horvath Mark W. |
Div. Pres., Breast & SkeletalO |
• – – |
2025-01-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,099 |
|
-23% |
|
| Schnittker Brandon |
Div. President, GYN Surgical |
• • – |
2024-12-13 |
4 |
D |
$73.65 |
$6,629 |
D/D |
(90) |
6,163 |
|
- |
|
| Madaus Martin D |
Director |
• • – |
2024-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
342 |
342 |
|
- |
|
| Mitchell Essex D |
Chief Operating Officer |
• • – |
2024-12-04 |
4 |
S |
$76.34 |
$1,897,482 |
D/D |
(24,856) |
27,957 |
|
27% |
|
| Mitchell Essex D |
Chief Operating Officer |
• • – |
2024-12-04 |
4 |
OE |
$40.97 |
$1,433,659 |
D/D |
22,902 |
52,813 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,180 |
11,360 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
39,677 |
1,241,138 |
|
- |
|
| Verstreken Jan |
Group President, International |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,298 |
104,444 |
|
- |
|
| Mitchell Essex D |
Chief Operating Officer |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
11,021 |
31,252 |
|
- |
|
| Schnittker Brandon |
Div. President, GYN Surgical |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,834 |
6,431 |
|
- |
|
| Schneiders Jennifer M |
President, Diag. Solutions |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,298 |
12,603 |
|
- |
|
| Anderson Erik S |
Div. Pres., Breast & Skeletal |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,723 |
23,621 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2024-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,298 |
183,634 |
|
- |
|
781 Records found
|
|
Page 1 of 32 |
|
|
0.56 (0.86%) 
